Choroidal Ischemia After Photodynamic Therapy With Verteporfin for Choroidal Neovascularization

Vincenzo Isola, Alfredo Pece, Maurizio Battaglia Parodi

Research output: Contribution to journalArticle

Abstract

Purpose: To report delay in choroidal perfusion suggestive of ischemia after photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV). Design: Observational case series. Methods: Retrospective review of all patients who developed choroidal ischemia after PDT. Results: This vascular change was found in eight (2.1%) of 373 eyes of patients treated for CNV as a result of age-related macular degeneration (AMD) and in one (0.9%) of 114 eyes treated for pathologic myopia. A decrease of 3 lines of vision was reported to occur one week after treatment in patients with AMD. At the 12-month examination, patients did not exhibit any marked changes in visual acuity. Conclusions: Choroidal ischemia was an uncommon manifestation owing to the selectivity of verteporfin therapy and the existence of abundant anastomotic vascular connections in the choroid. The low incidence of this vascular event should not preclude counseling PDT in eyes that could benefit greatly from this therapy.

Original languageEnglish
Pages (from-to)680-683
Number of pages4
JournalAmerican Journal of Ophthalmology
Volume142
Issue number4
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Choroidal Neovascularization
Photochemotherapy
Ischemia
Blood Vessels
Macular Degeneration
Choroid
Myopia
Visual Acuity
Counseling
Therapeutics
Perfusion
verteporfin
Incidence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Choroidal Ischemia After Photodynamic Therapy With Verteporfin for Choroidal Neovascularization. / Isola, Vincenzo; Pece, Alfredo; Parodi, Maurizio Battaglia.

In: American Journal of Ophthalmology, Vol. 142, No. 4, 10.2006, p. 680-683.

Research output: Contribution to journalArticle

@article{65ca99791c0344b98bca5a75d13a5c79,
title = "Choroidal Ischemia After Photodynamic Therapy With Verteporfin for Choroidal Neovascularization",
abstract = "Purpose: To report delay in choroidal perfusion suggestive of ischemia after photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV). Design: Observational case series. Methods: Retrospective review of all patients who developed choroidal ischemia after PDT. Results: This vascular change was found in eight (2.1{\%}) of 373 eyes of patients treated for CNV as a result of age-related macular degeneration (AMD) and in one (0.9{\%}) of 114 eyes treated for pathologic myopia. A decrease of 3 lines of vision was reported to occur one week after treatment in patients with AMD. At the 12-month examination, patients did not exhibit any marked changes in visual acuity. Conclusions: Choroidal ischemia was an uncommon manifestation owing to the selectivity of verteporfin therapy and the existence of abundant anastomotic vascular connections in the choroid. The low incidence of this vascular event should not preclude counseling PDT in eyes that could benefit greatly from this therapy.",
author = "Vincenzo Isola and Alfredo Pece and Parodi, {Maurizio Battaglia}",
year = "2006",
month = "10",
doi = "10.1016/j.ajo.2006.04.028",
language = "English",
volume = "142",
pages = "680--683",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Choroidal Ischemia After Photodynamic Therapy With Verteporfin for Choroidal Neovascularization

AU - Isola, Vincenzo

AU - Pece, Alfredo

AU - Parodi, Maurizio Battaglia

PY - 2006/10

Y1 - 2006/10

N2 - Purpose: To report delay in choroidal perfusion suggestive of ischemia after photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV). Design: Observational case series. Methods: Retrospective review of all patients who developed choroidal ischemia after PDT. Results: This vascular change was found in eight (2.1%) of 373 eyes of patients treated for CNV as a result of age-related macular degeneration (AMD) and in one (0.9%) of 114 eyes treated for pathologic myopia. A decrease of 3 lines of vision was reported to occur one week after treatment in patients with AMD. At the 12-month examination, patients did not exhibit any marked changes in visual acuity. Conclusions: Choroidal ischemia was an uncommon manifestation owing to the selectivity of verteporfin therapy and the existence of abundant anastomotic vascular connections in the choroid. The low incidence of this vascular event should not preclude counseling PDT in eyes that could benefit greatly from this therapy.

AB - Purpose: To report delay in choroidal perfusion suggestive of ischemia after photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV). Design: Observational case series. Methods: Retrospective review of all patients who developed choroidal ischemia after PDT. Results: This vascular change was found in eight (2.1%) of 373 eyes of patients treated for CNV as a result of age-related macular degeneration (AMD) and in one (0.9%) of 114 eyes treated for pathologic myopia. A decrease of 3 lines of vision was reported to occur one week after treatment in patients with AMD. At the 12-month examination, patients did not exhibit any marked changes in visual acuity. Conclusions: Choroidal ischemia was an uncommon manifestation owing to the selectivity of verteporfin therapy and the existence of abundant anastomotic vascular connections in the choroid. The low incidence of this vascular event should not preclude counseling PDT in eyes that could benefit greatly from this therapy.

UR - http://www.scopus.com/inward/record.url?scp=33748953200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748953200&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2006.04.028

DO - 10.1016/j.ajo.2006.04.028

M3 - Article

C2 - 17011867

AN - SCOPUS:33748953200

VL - 142

SP - 680

EP - 683

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 4

ER -